[1] PEREIRA L A,KLEJMAN M P,TIMMERS H T. Roles for BTAF1 and Mot1p in dynamics of TATA-binding protein and regulation of RNA polymerase Ⅱ transcription[J]. Gene, 2003, 315:1-13. [2] ODA T,KAYUKAWA K,HAGIWARA H, et al. A novel TATA-binding protein-binding protein, ABT1, activates basal transcription and has a yeast homolog that is essential for growth[J]. Mol Cell Biol, 2000, 20(4):1407-1418. [3] RAVARANI C H,CHALANCON G,BREKER M, et al. Affinity and competition for TBP are molecular determinants of gene expression noise[J]. Nat Commun, 2016, 7:10417. [4] ARKOVA O,KUZNETSOV N,FEDOROVA O, et al. A real-time study of the interaction of TBP with a TATA box-containing duplex identical to an ancestral or minor allele of human gene LEP or TPI[J]. J Biomol Struct Dyn, 2016, 35(14):3070-3081. [5] MAEDA R,TAMASHIRO H,TAKANO K, et al. TBP-like protein (TLP) disrupts the p53-MDM2 interaction and induces long-lasting p53 activation[J]. J Biol Chem, 2017, 292(8):3201-3212. [6] LOMVARDAS S,THANOS D. Nucleosome sliding via TBP DNA binding in vivo[J]. Cell, 2001, 106(6):685-696. [7] CHEN D,HINKLEY C S,HENRY RW, et al. TBP dynamics in living human cells:constitutive association of TBP with mitotic chromosomes[J]. Mol Biol Cell, 2002, 13(1):276-284. [8] TORA L. A unified nomenclature for TATA box binding protein (TBP)-associated factors (TAFs) involved in RNA polymerase Ⅱ transcription[J]. Genes Dev, 2002, 16(6):673-675. [9] ODA T, FUKUDA A,HAGIWARA H, et al. ABT1-associated protein (ABTAP), a novel nuclear protein conserved from yeast to mammals, represses transcriptional activation by ABT1[J]. J Cell Biochem, 2004, 93(4):788-806. [10] JOHNSON S A S,LIN J J,WALKEY C J, et al. Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer[J]. Oncotarget, 2017, 8(30):48832-48845. [11] YAN J,WEI Q,JIAN W, et al. IMP3 predicts invasion and prognosis in human lung adenocarcinoma[J]. Lung, 2016, 194(1):137-146. [12] CHEN W, GUO W, LI M, et al. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation[J]. PLoS ONE, 2013, 8(12):e82728. [13] KIM H Y, CHO Y, KANG H, et al. Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer[J]. Oncotarget, 2016, 7(31):49902-49916. [14] KIM S J, HWANG J A, RO J Y, et al. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer[J]. Oncotarget, 2013, 4(9):1461-1471. [15] GARATTINI S K,BASILE D,CATTANEO M, et al.Molecular classifications of gastric cancers:Novel insights and possible future applications[J]. World J Gastrointest Oncol, 2017, 9(5):194-208. [16] WANG Z,LIU C. Lgr5-positive cells are cancer-stem-cell-like cells in gastric cancer[J]. Cell Physiol Biochem, 2015, 36(6):2447-2455. [17] LI Y,YANG X,WU Y, et al. B7-H3 promotes gastric cancer cell migration and invasion[J]. Oncotarget, 2017,8(42):71725-71735. [18] ZHOU Y,ZHANG G J,WANG J, et al. Current status of lymph node micrometastasis in gastric cancer[J]. Oncotarget, 2017, 8(31):51963-51969. [19] EGELAND E V,FLATMARK K, NESLAND J M, et al. Expression and clinical significance of Wee1 in colorectal cancer[J]. Tumour Biol, 2016, 37(9):12133-12140. [20] CRIGHTON D,WOIWODE A,ZHANG C, et al. p53 represses RNA polymerase Ⅲ transcription by targeting TBP and inhibiting promoter occupancy by TFⅢB[J]. EMBO J, 2003, 22(11):2810-2820. [21] SZÁSZ A M,LÁNCZKY A,NAGY Á, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1065 patients[J]. Oncotarget, 2016, 7(31):49322-49333. |